McGill Alert / Alerte de McGill

Updated: Fri, 07/12/2024 - 12:16

McGill Alert. The downtown campus will remain partially closed through the evening of Monday, July 15. See the Campus Safety site for details.

Alerte de McGill. Le campus du centre-ville restera partiellement fermé jusqu’au lundi 15 juillet, en soirée. Complément d’information : Direction de la protection et de la prévention

Khashayar Esfahani

Academic title(s): 

Associate Member, McGill Centre for Translational Research in Cancer
Assistant Professor, Jewish General Hospital, Department of Oncology, McGill University

Khashayar Esfahani
Contact Information
Address: 

Jewish General Hospital
3755 Cote-Ste-Catherine, room E710
Montreal, Quebec
H3T 1E2

Phone: 
514 340 8222
Email address: 
khashayar.esfahani [at] mail.mcgill.ca
Group: 
Immunotherapy
Current research: 

Dr. Esfahani's research focus is on the study of immune checkpoint inhibitors (ICI). These inhibitors are among the most promising approaches to fight cancer. The use of these agents that enhance the host’s immune system to fight tumors has led to astounding outcomes in previously refractory cancers. The enhancement of immunity with ICI is also responsible for serious, undesirable off-target immune and inflammatory events known as immune-related adverse events (irAE). Although some can be transient, others require immunosuppressive therapy and discontinuation of ICI. Dr. Esfahani's vision is to identify mechanisms driving irAE with the hope of designing mitigation strategies that would allow for a safer and more targeted delivery of ICI

Back to top